BUSINESS BRIEFING / PHARMACEUTICALS
- Share via
Times Wire Reports
A suspicious surge in trading of Schering-Plough Corp. shares just before news of a merger deal with fellow drug maker Merck & Co. is being investigated by federal regulators, according to a published report.
The Securities and Exchange Commission is looking to see whether any trades were made by people with inside knowledge about the merger talks, unidentified people familiar with the situation told the Wall Street Journal.
Spokesmen at the SEC and both companies declined to comment.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
